
City Therapeutics Inc.
CTY | NASDAQ
$20.88
+$0.17 (+0.82%)
At close: Nov 2, 2026, 4:00 PM ET
TTM Period Ending | Q2 2020 Jun 30, 2020 | Q1 2020 Mar 31, 2020 | Q4 2019 Dec 31, 2019 | Q3 2019 Sep 30, 2019 | Q2 2019 Jun 30, 2019 | Q1 2019 Mar 31, 2019 | Q4 2018 Dec 31, 2018 | Q3 2018 Sep 30, 2018 | Q2 2018 Jun 30, 2018 | Q1 2018 Mar 31, 2018 | Q4 2017 Dec 31, 2017 | Q3 2017 Sep 30, 2017 | Q2 2017 Jun 30, 2017 | Q1 2017 Mar 31, 2017 | Q4 2016 Dec 31, 2016 | Q3 2016 Sep 30, 2016 | Q2 2016 Jun 30, 2016 | Q1 2016 Mar 31, 2016 | Q4 2015 Dec 31, 2015 | Q3 2015 Sep 30, 2015 | Q2 2015 Jun 30, 2015 | Q1 2015 Mar 31, 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Cash & Equivalents | 5M | 8M | 2M | 3M | 7M | 9M | 5M | 6M | 11M | 6M | 1M | 4M | 6M | 18M | 5M | 7M | 4M | 4M | 3M | 9M | 6M | 6M |
Short-Term Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Long-Term Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Long-Term Assets | 185M | 565M | 515M | 785M | 879M | 993M | 407M | 1.13B | 1.24B | 463M | 454M | 487M | 516M | 542M | 567M | 603M | 637M | 669M | 705M | 717M | 2.78B | 2.92B |
Receivables | 413M | 470M | 514M | 505M | 526M | 539M | 546M | 592M | 562M | 577M | 646M | 684M | 620M | 637M | 700M | 679M | 688M | 676M | 688M | 706M | 693M | 709M |
Inventory | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Current Assets | 623M | 846M | 1.97B | 1.75B | 1.6B | 1.42B | 1.3B | 947M | 1.9B | 1.36B | 1.12B | 974M | 971M | 1.09B | 1B | 1.11B | 959M | 1.33B | 911M | 1.67B | 1.5B | 1.39B |
Total Current Assets | 1.04B | 1.32B | 2.49B | 2.25B | 2.13B | 1.97B | 1.85B | 1.55B | 2.47B | 1.94B | 1.77B | 1.66B | 1.6B | 1.74B | 1.71B | 1.8B | 1.65B | 2.01B | 1.6B | 2.39B | 2.2B | 2.11B |
Property-Plant & Equipment | 8.29B | 8.21B | 8.17B | 8.1B | 8.03B | 8.01B | 8.08B | 7.94B | 7.94B | 7.95B | 7.92B | 7.94B | 7.81B | 7.67B | 7.65B | 7.51B | 7.44B | 7.41B | 7.37B | 7.29B | 7.22B | 7.18B |
Goodwill & Intangibles | 9.93B | 9.67B | 9.83B | 9.69B | 9.7B | 9.72B | 10.25B | 9.69B | 9.7B | 10.6B | 10.72B | 10.85B | 10.97B | 11.1B | 11.23B | 11.37B | 11.5B | 11.65B | 11.79B | 11.94B | 10.06B | 10.11B |
Total Long-Term Assets | 18.41B | 18.45B | 18.51B | 18.58B | 18.61B | 18.72B | 18.74B | 18.76B | 18.89B | 19.01B | 19.1B | 19.28B | 19.3B | 19.31B | 19.44B | 19.48B | 19.58B | 19.72B | 19.87B | 20.11B | 20.22B | 20.39B |
Total Assets | 19.45B | 19.77B | 21B | 20.83B | 20.74B | 20.68B | 20.58B | 20.31B | 21.36B | 20.95B | 20.87B | 20.94B | 20.89B | 21.06B | 21.15B | 21.27B | 21.23B | 21.73B | 21.47B | 22.5B | 22.42B | 22.49B |
Account Payables | 288M | 347M | 403M | 412M | 345M | 366M | 441M | 298M | 289M | 300M | 317M | 366M | 358M | 430M | 398M | 377M | 350M | 445M | 369M | 491M | 478M | 482M |
Deferred Revenue | 185M | 200M | 201M | 205M | 223M | 221M | 212M | 249M | 209M | 101M | 128M | 130M | 125M | 128M | 131M | 121M | 123M | 124M | 137M | 161M | 321M | 329M |
Short-Term Debt | 302M | 3M | 1.11B | 7M | 9M | 9M | 11M | 13M | 15M | 17M | 17M | 24M | 17M | 515M | 514M | 509M | 509M | 243M | 242M | 644M | 248M | 112M |
Other Current Liabilities | 1.62B | 1.66B | 1.7B | 1.6B | 1.6B | 1.59B | 1.61B | 1.57B | 1.56B | 1.7B | 1.73B | 1.68B | 1.67B | 1.65B | 1.75B | 1.71B | 1.67B | 1.71B | 1.67B | 1.62B | 1.35B | 1.43B |
Total Current Liabilities | 2.39B | 2.21B | 3.41B | 2.23B | 2.18B | 2.19B | 2.27B | 2.13B | 2.07B | 2.12B | 2.2B | 2.2B | 2.17B | 2.72B | 2.8B | 2.72B | 2.66B | 2.52B | 2.42B | 2.92B | 2.4B | 2.35B |
Long-Term Debt | 4.36B | 4.85B | 4.85B | 5.95B | 5.95B | 5.95B | 5.95B | 5.95B | 7.26B | 7.26B | 7.26B | 7.26B | 7.27B | 6.75B | 6.75B | 6.75B | 6.73B | 7.22B | 7B | 7.12B | 7.11B | 7.36B |
Other Long-Term Liabilities | 714M | 518M | 515M | 559M | 557M | 550M | 547M | 448M | 341M | 80M | 82M | 90M | 91M | 86M | 66M | 55M | 61M | 56M | 60M | 61M | 67M | 79M |
Total Long-Term Liabilities | 6.26B | 6.67B | 6.67B | 7.61B | 7.63B | 7.66B | 7.68B | 7.59B | 8.77B | 8.44B | 8.48B | 9.17B | 9.19B | 8.7B | 8.72B | 8.77B | 8.77B | 9.28B | 9.09B | 9.32B | 9.39B | 9.75B |
Total Liabilities | 9.32B | 9.66B | 10.88B | 10.62B | 10.61B | 10.68B | 10.72B | 10.49B | 11.66B | 11.4B | 11.53B | 12.25B | 12.27B | 12.35B | 12.46B | 12.47B | 12.43B | 12.82B | 12.56B | 13.51B | 13.05B | 13.36B |
Total Debt | 4.66B | 4.85B | 5.95B | 5.95B | 5.96B | 5.96B | 5.96B | 5.96B | 7.28B | 7.28B | 7.28B | 7.29B | 7.28B | 7.26B | 7.26B | 7.26B | 7.24B | 7.46B | 7.24B | 7.76B | 7.36B | 7.47B |
Book Value | 10.12B | 10.12B | 10.12B | 10.21B | 10.13B | 10.01B | 9.87B | 9.82B | 9.7B | 9.55B | 9.34B | 8.69B | 8.63B | 8.71B | 8.69B | 8.8B | 8.8B | 8.91B | 8.91B | 8.99B | 9.37B | 9.13B |
Book Value Per Share | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Common Stock | 10.05B | 10.05B | 10.05B | 10.05B | 10.05B | 10.05B | 10.05B | 10.05B | 10.05B | 10.05B | 10.05B | 10.05B | 10.05B | 10.05B | 10.05B | 10.05B | 10.05B | 10.05B | 10.05B | 10.05B | 10.05B | 10.05B |
Retained Earnings | 73M | 68M | 67M | 159M | 82M | -45M | -182M | -231M | -353M | -505M | -713M | -1.36B | -1.42B | -1.34B | -1.36B | -1.25B | -1.25B | -1.14B | -1.14B | -1.06B | -682M | -920M |
Comprehensive Income | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -3M | n/a | n/a | n/a | n/a |
Shareholders Equity | 10.12B | 10.12B | 10.12B | 10.21B | 10.13B | 10.01B | 9.87B | 9.82B | 9.7B | 9.55B | 9.34B | 8.69B | 8.63B | 8.71B | 8.69B | 8.8B | 8.8B | 8.91B | 8.91B | 8.99B | 9.37B | 9.13B |
Total Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Add to Watchlist
Select watchlists to add or remove CTY